Stock Alert: Co-Diagnostics Inc. (CODX)

(RTTNews) - Shares of Co-Diagnostics Inc. (CODX) are rising over 4% in pre-market today, after the company announced that it has contracted with Promega Corp. for additional manufacturing capacity for immediate production of the company's Logix Smart COVID-19 test, as the company seeks to expand its domestic outreach to public and private laboratories in the United States.

The Logix Smart COVID-19 test is currently available to all clinical laboratories certified under Clinical Laboratory Improvement Amendments (CLIA), and is authorized to be used for the diagnosis of SARS-CoV-2, the virus that causes COVID-19.

CODX has been trading in the range of $0.69 - $21.75 for the past one year, and closed Monday's trade at $9.93, up $1.13 or 12.84%. The stock is currently trading at $10.40 up 47 cents or 4.73% in the pre-market trading session.